Total raised
$26.5M
Last: Series A 2025-05
Stage
Series A
Founded
2020
Headcount
33
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
SpotitEarly develops scent based multi-cancer early detection screening test, combining proprietary AI stack with bio-detectors, to detect cancer at its early stages and save people’s lives.
Spotitearly is currently conducting a large clinical trial for screening breast, lung, colon and prostate cancers in one test. During training phase, the test showed higher sensitivity and better specificity in detecting early stages of cancer compared to any existing test on the market today.
Funding history · 2 rounds · $26.5M total
2025-05
Series A
$20.3M
2022-06
Seed
$6.2M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is SpotitEarly's core technology for cancer detection?
- SpotitEarly develops a scent-based multi-cancer early detection screening test that combines a proprietary AI stack with bio-detectors.
- What types of cancer is SpotitEarly's clinical trial currently screening for?
- SpotitEarly is currently conducting a large clinical trial for screening breast, lung, colon, and prostate cancers in one test.
- When was SpotitEarly founded?
- SpotitEarly was founded in June 2020.
- What was SpotitEarly's first funding round, and who were the lead investors?
- In June 2022, SpotitEarly raised a Seed round of $6.2 million. Hanaco Ventures was a lead investor.
- What was SpotitEarly's most recent funding round, and when did it occur?
- In May 2025, SpotitEarly completed a Series A funding round, raising $20.3 million. Hanaco Ventures was a lead investor.
- Which organization recognized SpotitEarly as a "Fierce 15" company?
- In March 2026, Fierce Healthcare named SpotitEarly a "Fierce 15" Company of 2026.
- With which institution did SpotitEarly announce a strategic partnership in January 2026?
- In January 2026, Fox Chase Cancer Center announced a strategic partnership with SpotitEarly to bolster the validity of its early cancer detection technology.
- How many employees does SpotitEarly currently have?
- SpotitEarly currently has 33 employees.
- Which Israeli government entity provided a grant to SpotitEarly?
- In January 2025, SpotitEarly received a grant from the IIA (Israel Innovation Authority).
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
Artificial IntelligenceDeep Learning
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business model
B2B
Tags
cancerdogsartificial-intelligencehealthcarecancer-diagnostics